Blair William & CO Ardelyx, Inc. Transaction History

Blair William & CO

$32 Billion
Q2 2024

A detailed history of Blair William & CO transactions in Ardelyx, Inc. stock. As of the latest transaction made, Blair William & CO holds 14,785 shares of ARDX stock, worth $85,605. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,785

Previous 14,785 -0.0%

Holding current value

$85,605

Previous $107,000 1.87%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$6.05 - $9.74 $1,724 - $2,775	285 Added 1.97%	14,785 $107,000
Q4 2023 Feb 12, 2024	BUY	$3.29 - $6.64 $47,705 - $96,280	14,500 New	14,500 $89,000
Q2 2022 Aug 10, 2022	SELL	$0.51 - $1.17 $6,375 - $14,625	-12,500 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.65 - $1.18 $3,250 - $5,900	-5,000 Reduced 28.57%	12,500 $13,000
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $1,290 - $2,550	-1,500 Reduced 7.89%	17,500 $19,000
Q3 2021 Nov 12, 2021	SELL	$1.27 - $8.17 $7,620 - $49,020	-6,000 Reduced 24.0%	19,000 $25,000
Q2 2021 Aug 12, 2021	SELL	$6.55 - $8.98 $655 - $898	-100 Reduced 0.4%	25,000 $190,000
Q1 2021 May 13, 2021	BUY	$6.1 - $7.69 $610 - $769	100 Added 0.4%	25,100 $166,000
Q4 2019 Feb 13, 2020	SELL	$4.23 - $8.29 $12,690 - $24,869	-3,000 Reduced 10.71%	25,000 $188,000
Q3 2019 Nov 12, 2019	BUY	$2.15 - $6.28 $6,450 - $18,840	3,000 Added 12.0%	28,000 $132,000
Q2 2019 Aug 13, 2019	BUY	$2.49 - $3.73 $62,250 - $93,250	25,000 New	25,000 $67,000

Others Institutions Holding ARDX

# of Institutions

210

Shares Held

144M

Call Options Held

1.01M

Put Options Held

1.43M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $895M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account